Charles River Laboratories International, Inc.
CRLFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/28/2024
Revenue
4,050
Cost of Revenue
2,718
Gross Profit
1,332
Gross Margin
32.9%
Operating Income
227
Operating Margin
5.6%
Net Income
10
Net Margin
0.3%
EPS (Basic)
$0.20
EPS (Diluted)
$0.20
EBITDA
581
EBITDA Margin
14.3%
2023
12/31/2023
Revenue
4,129
Cost of Revenue
2,627
Gross Profit
1,503
Gross Margin
36.4%
Operating Income
617
Operating Margin
14.9%
Net Income
475
Net Margin
11.5%
EPS (Basic)
$9.27
EPS (Diluted)
$9.22
EBITDA
1,032
EBITDA Margin
25.0%
2022
12/31/2022
Revenue
3,976
Cost of Revenue
2,513
Gross Profit
1,463
Gross Margin
36.8%
Operating Income
651
Operating Margin
16.4%
Net Income
486
Net Margin
12.2%
EPS (Basic)
$9.57
EPS (Diluted)
$9.48
EBITDA
986
EBITDA Margin
24.8%
2021
12/31/2021
Revenue
3,540
Cost of Revenue
2,206
Gross Profit
1,335
Gross Margin
37.7%
Operating Income
590
Operating Margin
16.7%
Net Income
391
Net Margin
11.0%
EPS (Basic)
$7.77
EPS (Diluted)
$7.60
EBITDA
820
EBITDA Margin
23.2%
2020
12/31/2020
Revenue
2,924
Cost of Revenue
1,850
Gross Profit
1,074
Gross Margin
36.7%
Operating Income
433
Operating Margin
14.8%
Net Income
364
Net Margin
12.5%
EPS (Basic)
$7.35
EPS (Diluted)
$7.20
EBITDA
768
EBITDA Margin
26.3%